Gainers
- Biomerica, Inc. BMRA shares climbed 38.3% to $6.23. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.
- Progenity, Inc. PROG gained 23% to $1.87 after jumping over 40% on Thursday.
- Atea Pharmaceuticals, Inc. AVIR climbed 21.3% to $42.52 following data from Merck & Co's investigational oral antiviral molnupiravir, which boosted sentiment for Atea Pharmaceutical's AT-527, an oral antiviral drug candidate.
- Sono-Tek Corporation SOTK surged 14.4% to $4.69.
- Ramaco Resources, Inc. METC gained 14% to $14.03.
- Salem Media Group, Inc. SALM rose 13.7% to $4.22.
- Quotient Limited QTNT gained 13.2% to $2.65. Quotient reported commencement of review process of expanded immunohematology technical file dossier by European Notified Body.
- Bitfarms Ltd. BITF surged 13% to $4.8050 amid an increase in the price of Bitcoin and Ethereum.
- Silverback Therapeutics, Inc. SBTX gained 12.6% to $11.24.
- SunPower Corporation SPWR rose 11.9% to $25.36. SunPower will replace Cimarex Energy in the S&P MidCap 400 effective on Tuesday, October 5.
- Luby's, Inc. LUB gained 11.4% to $4.6550.
- Merck & Co., Inc. MRK jumped 9.4% to $82.17 after the company and Ridgeback announced investigational oral antiviral molnupiravir reduced risk of hospitalization or death by about 50% versus the placebo for patients with mild to moderate COVID-19 in Phase 3 interim analysis.
- Iterum Therapeutics plc ITRM gained 8.2% to $0.6040 after dropping over 8% on Thursday.
- QuickLogic Corporation QUIK rose 8.2% to $5.80. QuickLogic reported a strategic investment by current shareholders. The company said it expects Q3 revenue of $3.8 million to $3.9 million.
- Molecular Data Inc. MKD rose 8.4% to $0.3810. Molecular Data recently closed its $15 million registered direct offering.
- Aeterna Zentaris Inc. AEZS rose 8.9% to $0.8167 after climbing over 25% on Thursday.
Check out these big penny stock gainers and losers
Losers
- Omeros Corporation OMER fell 43.5% to $7.79 after the company announced the FDA notified it that they identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.
- Spire Global, Inc.. SPIR shares tumbled 43.3% to $7.11. Spire Global, Inc. recently appointed Dr. Kevin Petty as Vice President of Weather.
- Adagio Therapeutics, Inc. ADGI fell 35.8% to $27.12. Adagio Therapeutics recently announced new data from its COVID-19 antibody program.
- NeuroBo Pharmaceuticals, Inc. NRBO dropped 28% to $2.68 after the company announced a 4.3 million share offering at $3.25 per share.
- IronNet, Inc.. IRNT shares fell 22.7% to $13.18 after dropping 15% on Thursday.
- Vir Biotechnology, Inc. VIR dropped 21.9% to $33.98 in reaction to promising data from competitor Merck's COVID-19 antiviral candidate.
- Immunome, Inc. IMNM fell 17.6% to $20.06. Immunome will present preclinical data on anti IL-38 antibody program at The American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
- Benson Hill Inc. BHIL fell 17.3% to $5.89.
- Superior Drilling Products, Inc. SDPI shares fell 16.6% to $1.4601 after jumping 60% on Thursday.
- Guardant Health, Inc. GH dipped 16.6% to $104.24 following a Bloomberg report suggesting the company is exploring an acquisition of NeoGenomics.
- Clarus Therapeutics Holdings, Inc. CRXT dropped 16.3% to $4.4591. Clarus Therapeutics filed for offer and sale of up to 19.82 million shares of common stock by selling stockholders.
- Novavax, Inc. NVAX fell 16.2% to $173.56 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.
- Farmmi, Inc. FAMI fell 16.1% to $0.3881. Farmmi recently agreed to acquire all the shares of Jiangxi Xiangbo Agriculture and Forestry Development Co., Ltd (Xiangbo) for about RMB70 million.
- Lordstown Motors Corp. RIDE shares fell 15.1% to $6.78. Lordstown Motors issued production and financial update. Foxconn will purchase $50 million of Lordstown common stock at price of $6.8983 per share.
- CureVac N.V. CVAC dropped 15% to $46.40 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.
- Camber Energy, Inc. CEI shares fell 14.7% to $3.26 after gaining over 11% on Thursday.
- Moderna, Inc. MRNA dropped 12.3% to $337.31 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. Stephane Bancel, Chief Executive Officer at Moderna, made a large insider sell on September 30, according to a new SEC filing.
- Alzamend Neuro, Inc. ALZN fell 11.3% to $2.73. Ascendiant Capital analyst Edward Woo initiated coverage on Alzamend Neuro with a Buy rating and announced price target of $8.
- BioNTech SE BNTX declined 10.2% to $245.21 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. BioNTech dosed the first patient with its individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in Phase 2 clinical trial.
ALZNAlzamend Neuro Inc
$0.6701-1.37%
Edge Rankings
Momentum
3.31
Price Trend
Short
Medium
Long
AVIRAtea Pharmaceuticals Inc
$2.86-%
BITFBitfarms Ltd
$0.84961.76%
BMRABiomerica Inc
$3.43-6.81%
BNTXBioNTech SE
$101.05-0.75%
CVACCureVac NV
$3.18-0.93%
FAMIFarmmi Inc
$1.54-5.61%
GHGuardant Health Inc
$42.49-0.28%
IMNMImmunome Inc
$7.60-5.00%
ITRMIterum Therapeutics PLC
$1.040.77%
METCRamaco Resources Inc
$9.803.38%
MRKMerck & Co Inc
$78.140.37%
MRNAModerna Inc
$25.220.36%
NVAXNovavax Inc
$6.020.17%
OMEROmeros Corp
$6.70-%
QUIKQuickLogic Corp
$4.53-%
SALMSalem Media Group Inc
$1.18352.3%
SOTKSono-Tek Corp
$3.60-2.44%
SPIRSpire Global Inc
$8.10-0.37%
SPWRComplete Solaria, Inc. - Common Stock
--%
VIRVir Biotechnology Inc
$5.61-%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in